<p>/PRNewswire/ -- Avalon Healthcare Solutions（&#34;Avalon&#34;）作为支付生态系统中值得信赖的诊断智能合作伙伴，今天宣布获得 WindRose Health Investors 的新多数投资，并继续得到现有投资者 Francisco Partners 的支持。这笔交易巩固了 Avalon 未来创新和增长的基础。</p>
<p>Avalon 支持超过 9000 万会员，并通过其专有的诊断洞察平台为 30 多个国家、地区和社区健康计划提供服务，该平台为其福利管理和分析解决方案提供动力。Avalon 的专利实时自动政策执行引擎（APEA）每月处理超过 1800 万项索赔，确保基于证据的、精准的和具有成本效益的诊断护理。</p>
<p><strong>推动诊断智能的下一个时代</strong></p>
<p>诊断信息影响 70% 的医疗决策，使诊断数据成为医疗保健中最强大且历史上未被充分利用的资产。Avalon 构建了唯一一个专注于大规模释放诊断的临床和财务价值的技术平台。</p>
<p>这项新投资将使 Avalon 能够：</p>
<ul>
<li>扩展其诊断智能能力</li>
<li>加速预测分析和基于证据的政策自动化的改进</li>
<li>加强其诊断洞察平台</li>
<li>扩展到新市场，包括为自筹资金雇主服务的 TPA 和经纪人，计划于 2026 年开始</li>
<li>为健康计划、提供者和会员提供更具量化价值的服务</li>
</ul>
<p><strong>对客户、合作伙伴和员工的承诺</strong></p>
<p>此次交易不会对运营、服务交付、服务水平协议、客户团队、定价或提供者关系产生任何变化。Avalon 的使命——成为释放诊断科学全部潜力的推动力——赋能医疗保健支付者和提供者，提供经过验证的解决方案以实现个性化护理和改善患者结果，保持不变，并因这项投资而进一步增强。</p>
<p>&#34;Avalon 正在进入一个令人兴奋的新篇章，&#34;Avalon 的首席执行官 Bill Kerr 博士表示。&#34;这项投资放大了我们所建立的势头，使我们能够加速客户所依赖的创新——从诊断政策自动化到先进分析，改变整个测试到治疗过程中的结果。&#34;</p>
<p>WindRose Health Investors 的合伙人 David Pontius 评论道：&#34;Avalon 处于诊断转型的核心。他们的平台、临床科学严谨性和可衡量的影响使他们在医疗保健生态系统中独特地定位于提供价值。我们很高兴能支持 Avalon 进入下一个规模阶段。&#34;</p>
<p>Francisco Partners 的合伙人 Ezra Pearlman 表示：&#34;我们的再投资反映了我们对 Avalon 使命、领导力和表现的坚定信念。Avalon 已经证明，诊断智能对于推动基于价值的护理至关重要，我们期待支持未来的旅程。&#34;</p>
<p><strong>关于 Avalon Healthcare Solutions</strong></p>
<p>Avalon 是诊断智能的领导者，帮助健康计划和提供者释放诊断科学的全部价值。我们简化复杂的诊断，加速经过验证的创新的采用，并优化诊断投资。通过我们的专有诊断洞察平台，我们整合基于证据的政策、策划的实验室网络和实时洞察，以改善健康结果、降低成本，并在大规模上实现个性化护理。凭借无与伦比的诊断专注、深厚的科学专业知识和经过验证的绩效模型，我们支持全国超过 30 个健康计划和 9000 多万会员——提供更智能的检测、更好的护理和可衡量的价值。有关 Avalon 的更多信息，请访问 <strong>www.avalonhcs.com</strong>。</p>
<p><strong>媒体联系人</strong>：</p>
<p>Michele Norton, MS, RN</p>
<p>Avalon Healthcare Solutions 产品营销高级副总裁</p>
<p>[email protected]</p>
<p>Janet Mordecai</p>
<p>Avalon Healthcare Solutions 的 Supreme Communications</p>
<p>[email protected]</p>
<p>来源：Avalon Healthcare Solutions</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2MzMxNCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUwNjA1UFJfTkVXU19VU1BSX19fX19MQTYzMzE0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2MzMxNCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUwNjA1UFJfTkVXU19VU1BSX19fX19MQTYzMzE0"/></p>

<p>Avalon Healthcare Solutions 宣布获得 WindRose Health Investors 的主要投资，得到了 Francisco Partners 的支持。这项投资旨在增强 Avalon 的诊断智能能力，改善预测分析，并扩展到新市场。Avalon 为超过 9000 万名会员提供服务，每月通过其诊断洞察平台处理 1800 万个索赔。该公司仍然致力于其使命，即在不改变运营或服务交付的情况下释放诊断科学的潜力。首席执行官 Bill Kerr 强调，这项投资将加速诊断政策自动化和分析方面的创新，提升患者的治疗效果</p>

<p>, /PRNewswire/ -- Avalon Healthcare Solutions (&#34;Avalon&#34;), a trusted partner for Diagnostic Intelligence across the payer ecosystem, today announced a new majority investment from WindRose Health Investors, with continued support from existing investor Francisco Partners. The transaction strengthens Avalon's foundation for future innovation and growth.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Avalon Healthcare Solutions（&#34;Avalon&#34;）作为支付生态系统中值得信赖的诊断智能合作伙伴，今天宣布获得 WindRose Health Investors 的新多数投资，并继续得到现有投资者 Francisco Partners 的支持。这笔交易巩固了 Avalon 未来创新和增长的基础。</p>
</div><p>Avalon supports more than 90 million members and serves over 30 national, regional, and community health plans through its proprietary Diagnostic Insights Platform, which powers its Benefit Management and Analytics solutions. Avalon's patented real-time automated policy enforcement engine (APEA) processes over 18 million claims per month, ensuring evidence-based, precise, and cost-effective diagnostic care.</p>
<div class="lb-trans"><p>Avalon 支持超过 9000 万会员，并通过其专有的诊断洞察平台为 30 多个国家、地区和社区健康计划提供服务，该平台为其福利管理和分析解决方案提供动力。Avalon 的专利实时自动政策执行引擎（APEA）每月处理超过 1800 万项索赔，确保基于证据的、精准的和具有成本效益的诊断护理。</p>
</div><p><strong>Driving the Next Era of Diagnostic Intelligence</strong></p>
<div class="lb-trans"><p><strong>推动诊断智能的下一个时代</strong></p>
</div><p>Diagnostics inform 70% of medical decisions, making diagnostic data one of the most powerful — and historically underleveraged — assets in healthcare. Avalon has built the only technology platform solely dedicated to unlocking clinical and financial value from diagnostics at scale.</p>
<div class="lb-trans"><p>诊断信息影响 70% 的医疗决策，使诊断数据成为医疗保健中最强大且历史上未被充分利用的资产。Avalon 构建了唯一一个专注于大规模释放诊断的临床和财务价值的技术平台。</p>
</div><p>This new investment will allow Avalon to:</p>
<div class="lb-trans"><p>这项新投资将使 Avalon 能够：</p>
</div><ul>
<li>Expand its Diagnostic Intelligence capabilities</li>
<li>Accelerate improvements in predictive analytics and evidence-based policy automation</li>
<li>Strengthen its Diagnostic Insights Platform</li>
<li>Scale into new markets, including TPAs and Brokers serving self-funded employers starting in 2026</li>
<li>Deliver even more quantifiable value to health plans, providers, and members</li>
</ul>
<div class="lb-trans"><ul>
<li>扩展其诊断智能能力</li>
<li>加速预测分析和基于证据的政策自动化的改进</li>
<li>加强其诊断洞察平台</li>
<li>扩展到新市场，包括为自筹资金雇主服务的 TPA 和经纪人，计划于 2026 年开始</li>
<li>为健康计划、提供者和会员提供更具量化价值的服务</li>
</ul>
</div><p><strong>Commitment to Clients, Partners, and Employees</strong></p>
<div class="lb-trans"><p><strong>对客户、合作伙伴和员工的承诺</strong></p>
</div><p>There will be no changes to operations, service delivery, SLAs, client teams, pricing, or provider relations as a result of the transaction. Avalon's mission — To be the driving force that unlocks the full potential of diagnostic science — empowering healthcare payers and providers with proven solutions that enable personalized care and enhance patient outcomes remains unchanged and is further strengthened by this investment.</p>
<div class="lb-trans"><p>此次交易不会对运营、服务交付、服务水平协议、客户团队、定价或提供者关系产生任何变化。Avalon 的使命——成为释放诊断科学全部潜力的推动力——赋能医疗保健支付者和提供者，提供经过验证的解决方案以实现个性化护理和改善患者结果，保持不变，并因这项投资而进一步增强。</p>
</div><p>&#34;Avalon is entering an exciting new chapter,&#34; said Bill Kerr, MD, CEO of Avalon. &#34;This investment amplifies the momentum we've built and enables us to accelerate the innovation our clients count on — from diagnostic policy automation to advanced analytics that transform outcomes across the entire test-to-treatment journey.&#34;</p>
<div class="lb-trans"><p>&#34;Avalon 正在进入一个令人兴奋的新篇章，&#34;Avalon 的首席执行官 Bill Kerr 博士表示。&#34;这项投资放大了我们所建立的势头，使我们能够加速客户所依赖的创新——从诊断政策自动化到先进分析，改变整个测试到治疗过程中的结果。&#34;</p>
</div><p>David Pontius, Partner at WindRose Health Investors, commented: &#34;Avalon stands at the heart of the diagnostics transformation. Their platform, clinical scientific rigor, and measurable impact make them uniquely positioned to deliver value across the healthcare ecosystem. We are thrilled to support Avalon in its next phase of scale.&#34;</p>
<div class="lb-trans"><p>WindRose Health Investors 的合伙人 David Pontius 评论道：&#34;Avalon 处于诊断转型的核心。他们的平台、临床科学严谨性和可衡量的影响使他们在医疗保健生态系统中独特地定位于提供价值。我们很高兴能支持 Avalon 进入下一个规模阶段。&#34;</p>
</div><p>Ezra Pearlman, Partner at Francisco Partners, stated: &#34;Our reinvestment reflects our strong conviction in Avalon's mission, leadership, and performance. Avalon has demonstrated that diagnostic intelligence is essential to driving value-based care, and we look forward to supporting the journey ahead.&#34;</p>
<div class="lb-trans"><p>Francisco Partners 的合伙人 Ezra Pearlman 表示：&#34;我们的再投资反映了我们对 Avalon 使命、领导力和表现的坚定信念。Avalon 已经证明，诊断智能对于推动基于价值的护理至关重要，我们期待支持未来的旅程。&#34;</p>
</div><p><strong>About Avalon Healthcare Solutions</strong></p>
<div class="lb-trans"><p><strong>关于 Avalon Healthcare Solutions</strong></p>
</div><p>Avalon is the leader in diagnostic intelligence, helping health plans and providers unlock the full value of diagnostic science. We simplify complex diagnostics, accelerate the adoption of proven innovations, and optimize diagnostic investments. Through our proprietary Diagnostic Insights Platform, we integrate evidence-based policies, curated lab networks, and real-time insights to improve health outcomes, reduce costs, and enable personalized care at scale. With an unmatched diagnostic focus, deep scientific expertise, and a proven performance-based model, we support over 30 health plans and more than 90 million members nationwide—delivering smarter testing, better care, and measurable value. For more information about Avalon, visit <strong>www.avalonhcs.com</strong>.</p>
<div class="lb-trans"><p>Avalon 是诊断智能的领导者，帮助健康计划和提供者释放诊断科学的全部价值。我们简化复杂的诊断，加速经过验证的创新的采用，并优化诊断投资。通过我们的专有诊断洞察平台，我们整合基于证据的政策、策划的实验室网络和实时洞察，以改善健康结果、降低成本，并在大规模上实现个性化护理。凭借无与伦比的诊断专注、深厚的科学专业知识和经过验证的绩效模型，我们支持全国超过 30 个健康计划和 9000 多万会员——提供更智能的检测、更好的护理和可衡量的价值。有关 Avalon 的更多信息，请访问 <strong>www.avalonhcs.com</strong>。</p>
</div><p><strong>Media Contacts</strong>:</p>
<div class="lb-trans"><p><strong>媒体联系人</strong>：</p>
</div><p>Michele Norton, MS, RN</p>
<div class="lb-trans"><p>Michele Norton, MS, RN</p>
</div><p>SVP Product Marketing, Avalon Healthcare Solutions</p>
<div class="lb-trans"><p>Avalon Healthcare Solutions 产品营销高级副总裁</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>Janet Mordecai</p>
<div class="lb-trans"><p>Janet Mordecai</p>
</div><p>Supreme Communications for Avalon Healthcare Solutions</p>
<div class="lb-trans"><p>Avalon Healthcare Solutions 的 Supreme Communications</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE Avalon Healthcare Solutions</p>
<div class="lb-trans"><p>来源：Avalon Healthcare Solutions</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2MzMxNCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUwNjA1UFJfTkVXU19VU1BSX19fX19MQTYzMzE0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA63314&amp;Transmission_Id=202601150605PR_NEWS_USPR_____LA63314&amp;DateId=20260115"/></p>

Avalon Healthcare Solutions 宣布进行战略投资，以加速诊断智能的未来发展